NGNE
Neurogene Inc.
Neurogene Inc. (NGNE) has 3 SEC Form 4 filings (7 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 8, 2026.
The most active filer is President and CFO Cvijic Christine Mikail with 5 filings. Insiders have net sold $640K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Rachel L. McMinn
- Employees:107
- HQ:New York City, NY, US
- IPO:2014-03-07
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$640K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$617.5M
latest known value
Related companies
Neurogene Inc. is in the Healthcare sector.